Alan Seth Krasner - Net Worth and Insider Trading
Alan Seth Krasner Net Worth
The estimated net worth of Alan Seth Krasner is at least $3 Million dollars as of 2024-11-08. Alan Seth Krasner is the Chief Medical Officer of Crinetics Pharmaceuticals Inc and owns about 43,210 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $3 Million. Details can be seen in Alan Seth Krasner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Seth Krasner has not made any transactions after 2023-10-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan Seth Krasner
Alan Seth Krasner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan Seth Krasner owns 2 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) , and Albireo Pharma Inc (ALBO) .
Click here to see the complete history of Alan Seth Krasner’s form 4 insider trades.
Insider Ownership Summary of Alan Seth Krasner
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CRNX | Crinetics Pharmaceuticals Inc | 2023-10-17 | Chief Medical Officer |
ALBO | Albireo Pharma Inc | 2012-09-30 | Chief Medical Officer |
Alan Seth Krasner Latest Holdings Summary
Alan Seth Krasner currently owns a total of 1 stock. Alan Seth Krasner owns 43,210 shares of Crinetics Pharmaceuticals Inc (CRNX) as of October 17, 2023, with a value of $3 Million.
Latest Holdings of Alan Seth Krasner
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CRNX | Crinetics Pharmaceuticals Inc | 2023-10-17 | 43,210 | 59.75 | 2,581,798 |
Holding Weightings of Alan Seth Krasner
Alan Seth Krasner Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan Seth Krasner has made a total of 2 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 7,000 shares on October 17, 2023, which brought Alan Seth Krasner around $210,000.
Insider Trading History of Alan Seth Krasner
- 1
Alan Seth Krasner Trading Performance
GuruFocus tracks the stock performance after each of Alan Seth Krasner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan Seth Krasner is -0.57%. GuruFocus also compares Alan Seth Krasner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan Seth Krasner within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan Seth Krasner's insider trading performs compared to the benchmark.
Performance of Alan Seth Krasner
Alan Seth Krasner Ownership Network
Ownership Network List of Alan Seth Krasner
Ownership Network Relation of Alan Seth Krasner
Alan Seth Krasner Owned Company Details
What does Crinetics Pharmaceuticals Inc do?
Who are the key executives at Crinetics Pharmaceuticals Inc?
Alan Seth Krasner is the Chief Medical Officer of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Development Officer Dana Pizzuti , See Remarks Marc Wilson , and Chief Scientific Officer Stephen F. Betz .
Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary
Over the past 18 months, Alan Seth Krasner made 1 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 7,000. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 40,035 shares made by Stephen F. Betz , a net sale of 159,049 shares made by Marc Wilson , and a net sale of 91,672 shares made by Dana Pizzuti .
In summary, during the past 3 months, insiders sold 46,410 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 46,410 shares. During the past 18 months, 913,970 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 908,970 shares.
Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crinetics Pharmaceuticals Inc Insider Transactions
Alan Seth Krasner Mailing Address
Above is the net worth, insider trading, and ownership report for Alan Seth Krasner. You might contact Alan Seth Krasner via mailing address: C/o Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Bldg. #2, San Diego Ca 92121.